Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Current Assets: 2009-2025

Historic Current Assets for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $37.5 million.

  • Rockwell Medical's Current Assets rose 9.64% to $37.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.5 million, marking a year-over-year increase of 9.64%. This contributed to the annual value of $37.0 million for FY2024, which is 28.71% up from last year.
  • Per Rockwell Medical's latest filing, its Current Assets stood at $37.5 million for Q3 2025, which was up 18.68% from $31.6 million recorded in Q2 2025.
  • Rockwell Medical's 5-year Current Assets high stood at $59.2 million for Q1 2021, and its period low was $24.8 million during Q1 2022.
  • Over the past 3 years, Rockwell Medical's median Current Assets value was $29.8 million (recorded in 2024), while the average stood at $31.3 million.
  • Its Current Assets has fluctuated over the past 5 years, first plummeted by 58.14% in 2022, then rose by 28.71% in 2024.
  • Quarterly analysis of 5 years shows Rockwell Medical's Current Assets stood at $35.3 million in 2021, then rose by 0.06% to $35.3 million in 2022, then declined by 18.52% to $28.8 million in 2023, then grew by 28.71% to $37.0 million in 2024, then grew by 9.64% to $37.5 million in 2025.
  • Its last three reported values are $37.5 million in Q3 2025, $31.6 million for Q2 2025, and $33.0 million during Q1 2025.